BCAB vs CCI · $5.9M cap vs P/E 40, rev $6.57B
Bioatla Inc (BCAB) versus Crown Castle (CCI) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Crown Castle (CCI) is a reit - specialty company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
BCAB currently screens at market cap $5.9M. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Not investment advice. Open the BCAB and CCI stock pages for the full models.
Not investment advice.